|
|
|
| Key opinion leaders will review provide a staging and treatment overview on follicular lymphoma and mantle cell lymphoma in the newly diagnosed, relapsed, and salvage settings. Case presentations will illustrate optimal nursing strategies. |
|
|
| |
|
|
|
| The latest treatment strategies for CML will be discussed. Key opinion leaders will review monitoring therapeutic response and nursing management of patients with CML. |
|
|
| |
|
|
|
| This activity will review effective nursing care plans for patients with NSCLC based on current evidence-based treatment approaches. |
|
|
| |
|
|
|
| This symposium will address three subsets of gastrointestinal malignancies: colorectal cancer, gastric cancer, and hepatocellular cancer. An overview of each disease entity, diagnostic work-up, risk factors, prognostic indicators, current and evolving treatment options, and treatment-related toxicities will be provided. |
|
|
| |
|
|
|
| The unique mechanisms of action of immunomodulatory antibodies will be described in detail. A synopsis of staging updates, risk factors, novel molecular profiling techniques, current treatment regimens, and clinical trial updates will also be covered. |
|
|
| |
|
|
|
| Key opinion leaders will present the latest evidence-based guidelines used in the management of bone loss, including new screening mechanisms and new agents to address bone health. The role of the oncology nurse in monitoring bone health and managing bone issues as patients work through the trajectory of cancer care will be emphasized. |
|
|
| |
|
|
|
| This program provides a comprehensive overview of screening, diagnosis, and treatment of ovarian cancer, including emerging therapies. Case studies highlighting common side effects such as neurotoxicity and peripheral neuropathy will be presented. |
|
|
| |